# Prednisolone in Active Ankylosing Spondylitis (AS)

> **NCT00244166** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 75 (—)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** prednisolone

## Key facts

- **NCT ID:** NCT00244166
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2008-08
- **Target enrollment:** 75 (—)
- **Last updated:** 2006-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244166, "Prednisolone in Active Ankylosing Spondylitis (AS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00244166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*